Keyword :   hyperuricemia

PREDICTION OF COMORBIDITY DEVELOPMENT IN PATIENTS WITH GOUT
Authors: Smiyan S.I. Makhovska O.Yu. Sverstyuk A.S. Migenko L.M.... №92 (2) 2023 / Review: 36
TREATMENT AND PREVENTION OF GOUT ATTACKS: FOCUS ON QUALITY
Author:Polyakova Daria №89–90 (3–4) 2022 / Review: 14
DIFFERENTIATED APPROACH TO URATE-LOWERING THERAPY OF GOUT DEPENDING ON AGE, SEX AND COMORBIDITIES
Authors: Krylova A.S. Dubkova A.G. Tsymbaliuk T.S. №86 (4) 2021 / Review: 25
PURIN METABOLISM DISORDERS AND INTESTINAL MICROBIOTA
Authors: Koval S. Snigurska I. Bozhko V.V. Miloslavsky D.... №86 (4) 2021 / Review: 32
A modern view of the pathogenetic aspects of gout (review)
Authors: Kondratiuk V.Е. Tarasenko O.М. №74 (4) 2018 / Review: 17
Association of lipid metabolism parameters and lipid ratios with serum uric acid levels in patients with stable ischemic heart disease: a single-center, cross-sectional study
Author:Svintsitskyi I.A. №69 (3) 2017 / Review: 16
The role of hyperuricemia in development of the cardiovascular diseases
Authors: Shuba N.M. Voronova T.D. Litvinenko S.V. №68 (2) 2017 / Review: 12
Hyperuricemia and gout: modern state problems
Authors: Kondratiuk V.Е. Tarasenko O.М. №65 (3) 2016 / Review: 16
Evaluation efficacy of slow action anti-inflammatory drugs in patients with knee osteoarthritis and hyperuricemia
Authors: Shuba N.M. Voronova T.D. Krylova А.S. Gulenko O.I. №62 (4) 2015 / Review: 17
Clinical features of osteoarthritis in combination with hyperuricemia
Authors: Shuba N.M. Voronova T.D. Krylova А.S. Pilipenko A.V.... №60 (2) 2015 / Review: 9
Pecularities of gouts’ course in association with the metabolic syndrome
Authors: Svintsitskyi A.S. Kozak N.P. Ostafiichuk A.S. №46 (4) 2011 / Review: 12
The efficacy of carvedilol in patients with essential hypertension associated with hyperuricemia
Authors: Koval S.N. Snegurskaya I.A. Bozhko V.V. Reznik L.A.... №46 (4) 2011 / Review: 25
PURINE EXCHANGE DISTURBANCES AND ARTERIAL HYPERTENSION
Authors: Koval S.N. Bozhko V.V. Mysnichenko O.V. №38 (4) 2009 г. / Review: 35